To explore whether SUMOylation of HK2 modulated the cancer cell aggressive phenotype, we performed proliferation curve analysis, BrdU incorporation, and anchorage-independent colony-formation assays to test cell proliferative activity and oncogenesis with different HK2 mutations. This evidence concerns the gene HK2 and cancer.